VBL Therapeutics preclinical data

In mice, once-daily 0.04 and 0.4 mg/kg doses of oral VB-201 for 5 days significantly delayed the onset of experimental autoimmune encephalomyelitis (EAE) vs. saline-treated controls (p=0.019 and p=0.0...